CRABP2 and ovarian carcinoma: Then we isolated tumor cells from the ascites of eight ovarian cancer patients, and detected their sensitivity to cisplatin (Fig. 2B) and CRABP2 expression levels (Fig. 2C), which showed that CRABP2 expression levels were positively correlated with the IC50 values (Fig. 2D).